AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: CBIO
Report Date: 2026-05-01
Full Report: https://amaly.io/stock/CBIO

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: BB
Description: CBIO, a biopharmaceutical company in the Unknown industry, demonstrates strong financial compliance with Shariah screening criteria, passing all major ratio thresholds under AAOIFI, MSCI, and S&P standards. However, due to its small market capitalization and low liquidity, it is not included in any major Shariah-compliant indices. The core business activities in rare disease therapeutics are permissible, with no non-compliant revenue identified. Overall, while financially compliant, index exclusion leads to a non-compliant classification for investment purposes. Purification is required for minor interest income exposure.

Primary Compliance Concerns:
- Exclusion from all major Shariah indices due to size and liquidity constraints
- Limited historical data for trend analysis in Unknown sector

Purification Requirement: 4.75%
Index Inclusion: Not included in S&P Dow Jones Shariah, MSCI Islamic, FTSE Shariah, or DJIM indices

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 0.0%
Liquidity Ratio: 0.0%
Interest Income Ratio: 0.0%
Purification Required: 4.75%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2025-11-30

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-22T12:00:00Z

---
Full interactive report: https://amaly.io/stock/CBIO
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.